Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich-Alexander Ludwig

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Pharmazie in Unserer Zeit|June 20, 2002
[Quality control in drugs--an international function]Friedrich-Alexander Ludwig
Molecules (Basel, Switzerland)|November 13, 2025
A Full-Spectrum Evaluation of Sigma-1 Receptor (S1R) Positron Emission Tomography (PET) Radioligands from Binding Affinity to Clinical ImagingFrancesco Mastropasqua, Friedrich-Alexander Ludwig, Carmen Abate
Molecules (Basel, Switzerland)|August 3, 2019
Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[<i>e</i>]imidazo[2,1-<i>c</i>][1,2,4]triazines as Phosphodiesterase 2A InhibitorsRien Ritawidya, Friedrich-Alexander Ludwig, Detlef Briel, et al.
Chemmedchem|June 13, 2019
Structure-Affinity Relationships of Fluorinated Spirocyclic σ<sub>2</sub> Receptor Ligands with an Exocyclic Benzylamino MoietyMelanie Bergkemper, Elisabeth Kronenberg, Dirk Schepmann, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
[<sup>18</sup>F]Fluspidine-A PET Tracer for Imaging of σ<sub>1</sub> Receptors in the Central Nervous SystemFriedrich-Alexander Ludwig, Erik Laurini, Judith Schmidt, et al.
Molecules (Basel, Switzerland)|September 13, 2016
LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine ReceptorsFriedrich-Alexander Ludwig, René Smits, Steffen Fischer, et al.
International Journal of Molecular Sciences|April 12, 2022
A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045 in Mice by LC-MS/MSXiao-Ning Chai, Friedrich-Alexander Ludwig, Anne Müglitz, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 3, 2017
Radiosynthesis of (S)-[<sup>18</sup>F]T1: The first PET radioligand for molecular imaging of α3β4 nicotinic acetylcholine receptorsJiradanai Sarasamkan, Steffen Fischer, Winnie Deuther-Conrad, et al.
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Validation of an LC-MS/MS Method to Quantify the New TRPC6 Inhibitor SH045 (Larixyl <i>N</i>-methylcarbamate) and Its Application in an Exploratory Pharmacokinetic Study in MiceXiao-Ning Chai, Friedrich-Alexander Ludwig, Anne Müglitz, et al.
EJNMMI Radiopharmacy and Chemistry|January 2, 2024
Preclinical evaluation of an <sup>18</sup>F-labeled N<sup>ε</sup>-acryloyllysine piperazide for covalent targeting of transglutaminase 2Robert Wodtke, Markus Laube, Sandra Hauser, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Pharmazie in Unserer Zeit|June 20, 2002
[Quality control in drugs--an international function]Friedrich-Alexander Ludwig
Molecules (Basel, Switzerland)|November 13, 2025
A Full-Spectrum Evaluation of Sigma-1 Receptor (S1R) Positron Emission Tomography (PET) Radioligands from Binding Affinity to Clinical ImagingFrancesco Mastropasqua, Friedrich-Alexander Ludwig, Carmen Abate
Molecules (Basel, Switzerland)|August 3, 2019
Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[<i>e</i>]imidazo[2,1-<i>c</i>][1,2,4]triazines as Phosphodiesterase 2A InhibitorsRien Ritawidya, Friedrich-Alexander Ludwig, Detlef Briel, et al.
Chemmedchem|June 13, 2019
Structure-Affinity Relationships of Fluorinated Spirocyclic σ<sub>2</sub> Receptor Ligands with an Exocyclic Benzylamino MoietyMelanie Bergkemper, Elisabeth Kronenberg, Dirk Schepmann, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
[<sup>18</sup>F]Fluspidine-A PET Tracer for Imaging of σ<sub>1</sub> Receptors in the Central Nervous SystemFriedrich-Alexander Ludwig, Erik Laurini, Judith Schmidt, et al.
Molecules (Basel, Switzerland)|September 13, 2016
LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine ReceptorsFriedrich-Alexander Ludwig, René Smits, Steffen Fischer, et al.
International Journal of Molecular Sciences|April 12, 2022
A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045 in Mice by LC-MS/MSXiao-Ning Chai, Friedrich-Alexander Ludwig, Anne Müglitz, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 3, 2017
Radiosynthesis of (S)-[<sup>18</sup>F]T1: The first PET radioligand for molecular imaging of α3β4 nicotinic acetylcholine receptorsJiradanai Sarasamkan, Steffen Fischer, Winnie Deuther-Conrad, et al.
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Validation of an LC-MS/MS Method to Quantify the New TRPC6 Inhibitor SH045 (Larixyl <i>N</i>-methylcarbamate) and Its Application in an Exploratory Pharmacokinetic Study in MiceXiao-Ning Chai, Friedrich-Alexander Ludwig, Anne Müglitz, et al.
EJNMMI Radiopharmacy and Chemistry|January 2, 2024
Preclinical evaluation of an <sup>18</sup>F-labeled N<sup>ε</sup>-acryloyllysine piperazide for covalent targeting of transglutaminase 2Robert Wodtke, Markus Laube, Sandra Hauser, et al.
Pageof 4